Literature DB >> 19747629

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Marcie Tomblyn1, Tom Chiller, Hermann Einsele, Ronald Gress, Kent Sepkowitz, Jan Storek, John R Wingard, Jo-Anne H Young, Michael J Boeckh, Michael A Boeckh.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19747629      PMCID： PMC3103296          DOI： 10.1016/j.bbmt.2009.06.019

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN： 1083-8791            Impact factor:   5.742


× No keyword cloud information.
  765 in total

1.  Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients.

Authors:  Michael Boeckh; Janet Englund; Yufeng Li; Carole Miller; Alan Cross; Humberto Fernandez; Jane Kuypers; Hyung Kim; John Gnann; Richard Whitley
Journal:  Clin Infect Dis       Date:  2006-12-05       Impact factor: 9.079

2.  Guideline for infection control in healthcare personnel, 1998. Hospital Infection Control Practices Advisory Committee.

Authors:  E A Bolyard; O C Tablan; W W Williams; M L Pearson; C N Shapiro; S D Deitchmann
Journal:  Infect Control Hosp Epidemiol       Date:  1998-06       Impact factor: 3.254

3.  Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors.

Authors:  S J Mitchell; J Gray; M E Morgan; M D Hocking; G M Durbin
Journal:  Lancet       Date:  1996-08-17       Impact factor: 79.321

4.  Human herpesvirus 8 DNA in serum during seroconversion in allogeneic bone marrow transplant recipients.

Authors:  Giuseppe Gentile; Angela Capobianchi; Antonio Volpi; Giorgio Palù; Francesca Pica; Arianna Calistri; Maria Angela Biasolo; Pietro Martino
Journal:  J Natl Cancer Inst       Date:  2005-07-06       Impact factor: 13.506

5.  Mycobacterial infections after kidney transplant.

Authors:  T Jie; A J Matas; K J Gillingham; D E R Sutherland; D L Dunn; A Humar
Journal:  Transplant Proc       Date:  2005-03       Impact factor: 1.066

6.  Late onset Pneumocystis carinii pneumonia following allogeneic bone marrow transplantation.

Authors:  O Lyytikäinen; T Ruutu; L Volin; I Lautenschlager; L Jokipii; L Tiittanen; P Ruutu
Journal:  Bone Marrow Transplant       Date:  1996-06       Impact factor: 5.483

7.  Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.

Authors:  Henry Masur; Jonathan E Kaplan; King K Holmes
Journal:  Ann Intern Med       Date:  2002-09-03       Impact factor: 25.391

8.  Tuberculin skin test positivity in pediatric allogeneic BMT recipients and donors in Turkey.

Authors:  Betul Tavil; Bora Gulhan; Ugur Ozcelik; Mualla Cetin; Ilhan Tezcan; Murat Tuncer; Duygu Uckan
Journal:  Pediatr Transplant       Date:  2007-06

9.  Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation.

Authors:  Deborah C Molrine; Joseph H Antin; Eva C Guinan; Robert J Soiffer; Kristin MacDonald; Richard Malley; Frank Malinoski; Susan Trocciola; Marjorie Wilson; Donna M Ambrosino
Journal:  Blood       Date:  2002-09-19       Impact factor: 22.113

Review 10.  Graft-versus-leukemia reactions in allogeneic chimeras.

Authors:  Hans-Jochem Kolb; Christoph Schmid; A John Barrett; Dolores J Schendel
Journal:  Blood       Date:  2003-09-04       Impact factor: 22.113
View more
  402 in total

1.  Vaccination of oncology patients: an effective tool and an opportunity not to be missed.

Authors:  Camille N Kotton; Mark C Poznansky
Journal:  Oncologist       Date:  2012-01-12

2.  Hepatitis C clinic operated by infectious disease specialists at a comprehensive cancer center: help is on the way.

Authors:  Harrys A Torres; Javier A Adachi; Lillian R Roach; Kathleen M Smith; Parag S Mahale; Marta Davila; Issam I Raad
Journal:  Clin Infect Dis       Date:  2012-03-01       Impact factor: 9.079

3.  Assessing responses to treatment of opportunistic mycoses and salvage strategies.

Authors:  Baldeep Wirk; John R Wingard
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

4.  Efficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation.

Authors:  Margaret L Green; Wendy Leisenring; Daniel Stachel; Steven A Pergam; Brenda M Sandmaier; Anna Wald; Lawrence Corey; Michael Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-07       Impact factor: 5.742

Review 5.  Rapid Fire: Infectious Disease Emergencies in Patients with Cancer.

Authors:  Stephanie Charshafian; Stephen Y Liang
Journal:  Emerg Med Clin North Am       Date:  2018-06-11       Impact factor: 2.264

6.  Bloodstream Infection Due to Vancomycin-resistant Enterococcus Is Associated With Increased Mortality After Hematopoietic Cell Transplantation for Acute Leukemia and Myelodysplastic Syndrome: A Multicenter, Retrospective Cohort Study.

Authors:  Genovefa A Papanicolaou; Celalettin Ustun; Jo-Anne H Young; Min Chen; Soyoung Kim; Kwang Woo Ahn; Krishna Komanduri; Caroline Lindemans; Jeffery J Auletta; Marcie L Riches
Journal:  Clin Infect Dis       Date:  2019-10-30       Impact factor: 9.079

Review 7.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.

Authors:  Juan Gea-Banacloche; Krishna V Komanduri; Paul Carpenter; Sophie Paczesny; Stefanie Sarantopoulos; Jo-Anne Young; Nahed El Kassar; Robert Q Le; Kirk R Schultz; Linda M Griffith; Bipin N Savani; John R Wingard
Journal:  Biol Blood Marrow Transplant       Date:  2016-10-14       Impact factor: 5.742

8.  Incidence rate of fluoroquinolone-resistant gram-negative rod bacteremia among allogeneic hematopoietic cell transplantation patients during an era of levofloxacin prophylaxis.

Authors:  Arianna Miles-Jay; Susan Butler-Wu; Ali Rowhani-Rahbar; Steven A Pergam
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-11       Impact factor: 5.742

Review 9.  Pharmacologic and clinical evaluation of posaconazole.

Authors:  Jason N Moore; Jason R Healy; Walter K Kraft
Journal:  Expert Rev Clin Pharmacol       Date:  2015-05       Impact factor: 5.045

Review 10.  Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know.

Authors:  M Ogata; T Fukuda; T Teshima
Journal:  Bone Marrow Transplant       Date:  2015-04-27       Impact factor: 5.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.